The association of early post-transplant glucose levels with long-term mortality

Diabetologia

Volumn 54, Issue 6, 2011, Pages 1341-1349

  Valderhaug, T G ^a,b   Hjelmesaeth J ^a,c   Hartmann, A ^b   Roislien J ^b,c   Bergrem, H A ^a   Leivestad, T ^a   Line, P D ^a   Jenssen, T ^a,d  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c VESTFOLD HOSPITAL TRUST   (Norway)

^d UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Mortality after renal transplantation; New onset post transplant diabetes mellitus; Oral glucose tolerance test; Post transplant complications

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HEART DEATH; HUMAN; KIDNEY TRANSPLANTATION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORAL GLUCOSE TOLERANCE TEST; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; AGED; BLOOD; CARDIOVASCULAR DISEASE; DIET RESTRICTION; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SURVIVAL RATE; TIME;

ADULT; AGED; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 80052554459     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-011-2105-9     Document Type: Article

References (38)

1. Briggs JD (2001) Causes of death after renal transplantation. Nephrol Dial Transplant 16:1545-1549
2. Miller LW (2002) Cardiovascular toxicities of immunosuppressive agents. Am J Transplant 2:807-818
3. Kasiske BL, Chakkera HA, Roel J (2000) Explained and unexplained ischemic heart disease risk after renal transplantation. J Am Soc Nephrol 11:1735-1743
4. Levitan EB, Song Y, Ford ES, Liu S (2004) Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A metaanalysis of prospective studies. Arch Intern Med 164:2147-2155 (Pubitemid 39410805)
5. Stattin P, Bjor O, Ferrari P et al (2007) Prospective study of hyperglycemia and cancer risk. Diab Care 30:561-567 (Pubitemid 46354334)
6. deVegt F, Dekker JM, Ruhe HG et al (1999) Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia 42:926-931 (Pubitemid 29369599)
7. DECODE study group (1999) Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe. Lancet 354:617-621
8. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ (2003) Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 3:178-185 (Pubitemid 36323115)
9. Revanur VK, Jardine AG, Kingsmore DB, Jaques BC, Hamilton DH, Jindal RM (2001) Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation. Clin Transplant 15:89-94 (Pubitemid 32229796)
10. Cosio FG, Pesavento TE, Kim S, Osei K, Henry M, Ferguson RM (2002) Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int 62:1440-1446
11. Hjelmesaeth J, Hartmann A, Leivestad T et al (2006) The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events. Kidney Int 69:588-595 (Pubitemid 43164454)
12. Miles AM, Sumrani N, Horowitz R et al (1998) Diabetes mellitus after renal transplantation: as deleterious as non-transplantassociated diabetes? Transplantation 65:380-384 (Pubitemid 28095966)
13. Valderhaug TG, Jenssen T, Hartmann A et al (2009) Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation. Transplantation 88:429-434
14. DECODE study group (1999) Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. The DECODE-study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis of Diagnostic Criteria in Europe. Diabetologia 42:647-654
15. Hofso D, Jenssen T, Hager H, Roislien J, Hjelmesaeth J (2010) Fasting plasma glucose in the screening for type 2 diabetes in morbidly obese subjects. Obes Surg 20:302-307
16. Valderhaug TG, Hjelmesaeth J, Rollag H et al (2007) Reduced incidence of new-onset posttransplantation diabetes mellitus during the last decade. Transplantation 84:1125-1130 (Pubitemid 350125354)
17. World Medical Association (2000) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 284:3043-3045
18. Rustad P, Felding P, Franzson L et al (2004) The Nordic Reference Interval Project 2000: recommended reference intervals for 25 common biochemical properties. Scand J Clin Lab Invest 64:271-284
19. D'Orazio P, Burnett RW, Fogh-Andersen N et al (2006) Approved IFCC recommendation on reporting results for blood glucose: International Federation of Clinical Chemistry and Laboratory Medicine Scientific Division, Working Group on Selective Electrodes and Point-of-Care Testing (IFCC-SD-WG-SEPOCT). Clin Chem Lab Med 44:1486-1490
20. American Diabetes Association (2010) Standards of Medical Care in Diabetes 2010. Diab Care 33:S11-S61
21. The Norwegian Renal Registry (2009) The Norwegian Renal Registry. Annual report 2008. Available from: www.nephro.no/ nnr/AARSM2008.pdf, accessed 17 Dec 2009
22. Svennevig JL, Bech J, Karlsen H, Amlie E, Olsen A (1995) From a registry to a clinical information system. Development of the Datacor system at the surgery department A, Rikshospitalet. Tidsskr Nor Laegeforen 115:1057-1059, article in Norwegian
23. Rollag H, Sagedal S, Kristiansen KI et al (2002) Cytomegalovirus DNA concentration in plasma predicts development of cytomegalovirus disease in kidney transplant recipients. Clin Microbiol Infect 8:431-434 (Pubitemid 34993821)
24. van Dijk PCW, Jager KJ, de Charro F et al (2001) Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries. Nephrol Dial Transplant 16:1120-1129 (Pubitemid 32547364)
25. Newgard CD, Haukoos JS (2007) Advanced statistics: missing data in clinical research - part 2: multiple imputation. Acad Emerg Med 14:669-678 (Pubitemid 46929089)
26. Royston P, Ambler G, Sauerbrei W (1999) The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol 28:964-974 (Pubitemid 29525041)
27. Harrell FE Jr, Lee KL, Mark DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361-387 (Pubitemid 26072233)
28. Pencina MJ, D'Agostino RB (2004) Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med 23:2109-2123
29. Metter EJ, Windham BG, Maggio M et al (2008) Glucose and insulin measurements from the oral glucose tolerance test and mortality prediction. Diab Care 31:1026-1030
30. Barr EL, Boyko EJ, Zimmet PZ, Wolfe R, Tonkin AM, Shaw JE (2009) Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study. Diabetologia 52:415-424
31. Sarwar N, Gao P, Seshasai SR et al (2010) Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375:2215-2222
32. Nakagami T (2004) Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin. Diabetologia 47:385-394
33. Department of Noncommunicable Disease Surveillance WHO (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1. Diagnosis and classification of diabetes mellitus. Geneva, World Health Organization. Available from: http://whqlibdoc.who.int/hq/ 1999/WHO-NCD-NCS-99.2.pdf. Accessed 13 March 2006
34. Barr EL, Zimmet PZ, Welborn TA et al (2007) Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation 116:151-157 (Pubitemid 47057520)
35. Department of Noncommunicable Disease Management WHO (2003) Screening for type 2 diabetes. Report of a World Health Organization and International Diabetes Federation meeting. Geneva, World Health Organization. Available from: http://whqlibdoc.who.int/ hq/2003/WHO-NMH-MNC-03.1.pdf. Accessed 23 June 2010
36. Armstrong KA, Prins JB, Beller EM et al (2006) Should an oral glucose tolerance test be performed routinely in all renal transplant recipients? Clin J Am Soc Nephrol 1:100-108
37. Bergrem HA, Valderhaug TG, Hartmann A et al (2010) Undiagnosed diabetes in kidney transplant candidates: a casefinding strategy. Clin J Am Soc Nephrol 5:616-622
38. Winkelmayer WC, Chandraker A (2008) Pottransplantation anemia: management and rationale. Clin J Am Soc Nephrol 3 (Suppl 2):S49-S55